Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test

NCT05176145 is registered in ClinicalTrials.gov with Vitadx as lead sponsor.

NCT NCT05176145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05176145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test
Lead sponsor
Vitadx
Phase
Not applicable
Overall status
Unknown status
Start date
April 5, 2022
Completion date
May 31, 2025
Enrollment
400 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

non-muscle invasive bladder cancer (nmibc)